- Home
- CUE vs SITC Comparison
CUE vs SITC Comparison
Compare CUE & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | SITC |
|---|---|---|
| Founded | 2014 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 154.8M |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CUE | SITC |
|---|---|---|
| Price | $27.77 | $3.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $88.00 | N/A |
| AVG Volume (30 Days) | 373.8K | ★ 1.3M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 94.64% |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $27,466,000.00 | ★ $123,649,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $2.80 |
| 52 Week High | $45.50 | $8.95 |
Technical Indicators
Market Signals| Indicator | CUE | SITC |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 45.83 |
| Support Level | $24.27 | $2.86 |
| Resistance Level | $33.11 | $3.11 |
| Average True Range (ATR) | 3.36 | 0.12 |
| MACD | -0.54 | 0.01 |
| Stochastic Oscillator | 43.15 | 17.09 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.